Targeting the glucagon receptor signaling pathway as a novel strategy to counteract PI3K inhibitor induced hyperglycemia while sustaining tumor PI3K inhibition.

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Wang, J; Osada, T; Morse, MA; Calzone, F; Yan, H; Thai, D; Lyerly, HK

Published Date

  • July 2021

Published In

Volume / Issue

  • 62 / 7

Start / End Page

  • 1761 - 1764

PubMed ID

  • 33576297

Electronic International Standard Serial Number (EISSN)

  • 1029-2403

Digital Object Identifier (DOI)

  • 10.1080/10428194.2021.1881504

Language

  • eng

Conference Location

  • United States